Dendritic cell-tumor cell hybrid vaccine (Genoa)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDendritic cell-tumor cell hybrid vaccine (Genoa)
Drug Alias Name树突细胞肿瘤细胞混合疫苗（Genoa）HybriCell
ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Renal CellMelanoma
Global Approved IndicationsCarcinoma, Renal CellMelanoma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryBrazil
Original Approved Date2004/01/01
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGenoa Biotecnologia
China Registration ClassN/A

Develop Information

Active CompaniesGenoa Biotecnologia
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal CellMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeJ07X
Related LinksWikipedia